155 related articles for article (PubMed ID: 30431147)
41. Poikilodermatous mycosis fungoides and atrophic large-plaque parapsoriasis exhibit similar abnormalities of T-cell antigen expression.
Lindae ML; Abel EA; Hoppe RT; Wood GS
Arch Dermatol; 1988 Mar; 124(3):366-72. PubMed ID: 3257858
[TBL] [Abstract][Full Text] [Related]
42. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
[TBL] [Abstract][Full Text] [Related]
43. Expression of PTEN in mycosis fungoides and correlation with loss of heterozygosity.
Katona TM; Smoller BR; Webb AL; Hattab EM; Khalil A; Hiatt KM
Am J Dermatopathol; 2013 Jul; 35(5):555-60. PubMed ID: 23715078
[TBL] [Abstract][Full Text] [Related]
44. Pityriasis Lichenoides, Atypical Pityriasis Lichenoides, and Related Conditions: A Study of 66 Cases.
Borra T; Custrin A; Saggini A; Fink-Puches R; Cota C; Vermi W; Facchetti F; Cerroni L
Am J Surg Pathol; 2018 Aug; 42(8):1101-1112. PubMed ID: 29851705
[TBL] [Abstract][Full Text] [Related]
45. Differential SATB1 Expression Reveals Heterogeneity of Cutaneous T-Cell Lymphoma.
Gao Y; Liu F; Sun J; Wen Y; Tu P; Kadin ME; Wang Y
J Invest Dermatol; 2021 Mar; 141(3):607-618.e6. PubMed ID: 32771472
[TBL] [Abstract][Full Text] [Related]
46. T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides.
Thurber SE; Zhang B; Kim YH; Schrijver I; Zehnder J; Kohler S
J Am Acad Dermatol; 2007 Nov; 57(5):782-90. PubMed ID: 17646032
[TBL] [Abstract][Full Text] [Related]
47. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
48. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides.
Kakinuma T; Sugaya M; Nakamura K; Kaneko F; Wakugawa M; Matsushima K; Tamaki K
J Am Acad Dermatol; 2003 Jan; 48(1):23-30. PubMed ID: 12522366
[TBL] [Abstract][Full Text] [Related]
49. miRNA in mycosis fungoides and skin inflammation.
Persson JL
APMIS; 2013 Nov; 121(11):1017-9. PubMed ID: 24106870
[TBL] [Abstract][Full Text] [Related]
50. Unilesional mycosis fungoides: clinical, microscopic and immunophenotypic features.
Oliver GF; Winkelmann RK; Banks PM
Australas J Dermatol; 1989; 30(2):65-71. PubMed ID: 2486174
[TBL] [Abstract][Full Text] [Related]
51. Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study.
Sigurdsson V; Toonstra J; Bihari IC; Bruijnzeel-Koomen CA; van Vloten WA; Thepen T
J Cutan Pathol; 2000 Oct; 27(9):429-35. PubMed ID: 11028812
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-93 Targets p21 and Promotes Proliferation in Mycosis Fungoides T Cells.
Gluud M; Fredholm S; Blümel E; Willerslev-Olsen A; Buus TB; Nastasi C; Krejsgaard T; Bonefeld CM; Woetmann A; Iversen L; Litman T; Geisler C; Ødum N; Lindahl LM
Dermatology; 2021; 237(2):277-282. PubMed ID: 32335549
[TBL] [Abstract][Full Text] [Related]
53. Altered microRNA expression in mycosis fungoides.
Maj J; Jankowska-Konsur A; Sadakierska-Chudy A; Noga L; Reich A
Br J Dermatol; 2012 Feb; 166(2):331-6. PubMed ID: 21966986
[TBL] [Abstract][Full Text] [Related]
54. Immunophenotypic correlation between skin biopsy and peripheral blood findings in mycosis fungoides.
Kelemen K; White CR; Gatter K; Braziel RM; Fan G
Am J Clin Pathol; 2010 Nov; 134(5):739-48. PubMed ID: 20959657
[TBL] [Abstract][Full Text] [Related]
55. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
56. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
[TBL] [Abstract][Full Text] [Related]
57. An asymptomatic scaly plaque. Unilesional mycosis fungoides (MF).
Evans LT; Mackey SL; Vidmar DA
Arch Dermatol; 1997 Feb; 133(2):231, 234. PubMed ID: 9041840
[No Abstract] [Full Text] [Related]
58. Mycosis fungoides progression could be regulated by microRNAs.
Manso R; Martínez-Magunacelaya N; Eraña-Tomás I; Monsalvez V; Rodríguez-Peralto JL; Ortiz-Romero PL; Santonja C; Cristóbal I; Piris MA; Rodríguez-Pinilla SM
PLoS One; 2018; 13(6):e0198477. PubMed ID: 29894486
[TBL] [Abstract][Full Text] [Related]
59. A Rare Case of Solitary Hemorrhagic Mycosis Fungoides With Angiocentric Features.
Belousova IE; Samtsov AV; Kazakov DV
Am J Dermatopathol; 2017 Apr; 39(4):313-315. PubMed ID: 27759700
[TBL] [Abstract][Full Text] [Related]
60. Expression of CD31 in Mycosis Fungoides.
Jankowska-Konsur A; Kobierzycki C; Grzegrzolka J; Piotrowska A; Gomulkiewicz A; Glatzel-Plucinska N; Olbromski M; Podhorska-Okolow M; Szepietowski JC; Dziegiel P
Anticancer Res; 2016 Sep; 36(9):4575-82. PubMed ID: 27630298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]